Recommended as Stock of the Week on January 4, 2026

RenaissanceRe: Reinsurance with pricing power

TickerRNR.NYSE
Recommended Price272.24 USD
Current Price 272.24 USD
Renaissancere Holdings Ltd – stock chart

Scores at time of recommendation (January 4, 2026)

Leeway Score
65/100
Excellent
Business Rating
67/100
Excellent
Market-Fit Rating
63/100
Fair
Cycle Rating
65/100
Fair

More about our scores in Help

5-year stock timeline

2021

Weather-related catastrophe losses totaled approximately $962.1M, creating a net negative impact on results. Despite this, the company reported net income of roughly $731.5M for the year. The market viewed this as evidence of catastrophe volatility inherent to the franchise, while recognizing that profitability persisted through the cycle. Stock price action remained volatile, with sensitivity to loss announcements driving drawdown risk. [28], [30]

Q3 2022

The company reported a net loss attributable to common shareholders of $825.3M and an operating loss of $396.7M. Market sentiment shifted as catastrophe losses and reserve pressure moved investor focus from steady compounding to capital and underwriting risk management. An extended drawdown followed through the remainder of the year. [27], [28]

2022 (full year)

Full-year net loss to common shareholders reached approximately $1.096B, with total investment results contributing a loss of roughly $1.2B and a combined ratio near 97.7%. This stress year—driven by large catastrophe hits and investment volatility—prompted management to signal a need for pricing discipline and balance-sheet strengthening. Stock price reached a trough relative to prior cycles. [28], [29], [30], [31]

January 2023 renewal season

Management implemented a "reset on rates" into the 1/1/2023 renewals to rebuild the margin of safety following elevated catastrophe losses. Market perception began shifting toward a pricing hardening cycle and a path back to attractive underwriting returns. Early signs of bottoming emerged as recovery began. [31]

May 22, 2023 — Validus acquisition announced

The company entered a definitive agreement to acquire AIG's Validus Re, including AlphaCat and Talbot treaty renewal rights, for $2.985B (approximately $2.735B in cash plus $250M in RenRe shares). The market viewed this as a strategic move to build scale and diversification through treaty reinsurance and ILS capability, while pricing in near-term financing and integration dilution. The transaction acted as a catalyst for accumulation and positive re-rating. [15], [14], [21], [22]

November 1, 2023 — Validus acquisition closed

The acquisition completed with AIG receiving cash and RenRe shares. Rating agencies took related actions around the close. Market focus shifted to integration execution, reserve arrangements, and synergy realization, with recognition of an enlarged property-catastrophe footprint. Initial post-close uplift was followed by consolidation as integration proceeded. [13], [18], [24], [34]

Q4 2023 / December 2023 — Bermuda tax enactment and deferred tax asset

Bermuda enacted a 15% corporate income tax effective January 1, 2025. RenRe recorded a net deferred tax asset of approximately $593.8M in Q4 2023, materially boosting book and tangible book value. The company reported strong Q4 and full-year operating income. This one-time book boost, combined with a "step-change" in property-catastrophe pricing, reframed the narrative from recovery to a high-return underwriting story. The stock rallied on improved fundamentals and enhanced book metrics. [37], [38], [4], [33]

January 1, 2024 renewals and 2024 outlook

At the 1/1/2024 renewals, RenRe retained legacy lines and expanded its share in property catastrophe and specialty without conceding pricing or terms. Validus integration continued to affect expense ratios. The market reinforced its view of pricing power and sustainable underwriting margins, treating the company as returning to durable high returns despite integration drag. The stock sustained an uptrend with episodic volatility tied to catastrophe news. [4], [3], [34]

H1–H2 2024 — continued underwriting strength and integration costs

Quarterly reports through 2024 reiterated strong operating returns with high annualized operating ROE in several quarters, while transaction, integration, and compensation expenses remained elevated. The market increasingly positioned RenRe as an underwriting compounder with temporary expense headwinds from Validus integration. Uptrend continued with pullbacks on event noise. [5], [3], [12], [34]

2025 — Bermuda tax effective; record operating performance; capital returns

Bermuda's 15% corporate tax became effective on January 1, 2025. RenRe delivered materially stronger full-year results (reported in early 2026) and executed large share repurchases and shareholder distributions. Despite higher statutory tax, the market rewarded sustained underwriting performance and disciplined capital allocation. Buybacks and dividends reinforced a value-return narrative. Mature uptrend continued with multiple positive re-ratings around earnings and capital-return announcements. [37], [40], [6], [11], [10], [8]

Q1–Q2 2025

Q1 2025 showed divergence between GAAP and operating metrics: reported net income available to common shareholders was $161.1M while operating loss attributable to common shareholders was $69.8M. Q2 2025 beat estimates with $376M in share repurchases. Short-term volatility emerged as GAAP results and one-offs created noise, but momentum remained driven by underlying underwriting and capital returns. Short pullbacks were followed by resumed uptrend. [1], [10], [11]

Full-year 2025 reported in early 2026

Full-year 2025 results showed record operating income and strong returns on equity, with tangible book value growth and heavy capital deployment through repurchases. This confirmed conversion to multi-year underwriting outperformance plus shareholder-friendly capital policy, with the market treating RenRe as a top-tier reinsurance franchise. Strong rally and valuation re-rating followed versus earlier cycle troughs. [6], [11]

Mid-2026 (as of July 11, 2026)

The stock is trading at $314.99. Q1 2026 and ongoing disclosures remain on the company investor site as the business operates post-Validus with continued underwriting focus and active capital management. Investors assign a premium for sustained underwriting returns, scale from Validus, and aggressive capital returns, while acknowledging cyclical exposure to large catastrophe years and market or investment volatility. The stock is in a mature uptrend and momentum phase; principal risk remains a sizable catastrophe or investment-market shock that would trigger a swift drawdown. [2], [6], [11]

Key Points

From recommendation (January 4, 2026)

  • Return on equity of 19.3% (2023) underlines first-class capital efficiency
  • Combined ratio of 77.9% signals excellent underwriting
  • Customers are legally obliged to reinsure - recession-resistant business
  • Share buyback program underway at attractive valuations
  • P/E ratio of 7.4 indicates undervaluation in the sector

Investment Thesis

From recommendation (January 4, 2026)

RenaissanceRe is a leading catastrophe reinsurer with exceptional operational discipline and structural competitive advantages. The company benefits from a business model in which customers are forced by regulation to reinsure and inflation and rising claims sums tend to lead to higher premiums. The strong capital base, coupled with intelligent capital allocation and an attractive valuation level, make the share an unusually solid player in an often volatile sector.

Key risks and downside factors

RenaissanceRe is a Bermuda-based global reinsurer with a focused mandate in property-catastrophe and specialty reinsurance. It competes against a diverse set: global reinsurers like Munich Re, Swiss Re, and Hannover Re; Bermuda-based specialists including Everest, Axis, and Arch; and hybrid players like Markel and Berkshire Hathaway that operate meaningful reinsurance franchises alongside insurance. The business carries three material risk dimensions. Catastrophe-loss volatility remains the structural anchor—large single events can swing results meaningfully. The reinsurance cycle itself creates pricing pressure, particularly as alternative capital and ILS competitors continue to absorb share in soft markets. Investment returns matter more than most realize; capital levels and credit ratings feed directly into underwriting capacity and client appetite, creating a feedback loop that compounds during stressed periods.

  • Material earnings and capital volatility stemming from major natural catastrophe losses, given RenaissanceRe's concentrated exposure to property-cat reinsurance.
  • Adverse reinsurance pricing cycles and intense competition from large reinsurers, specialty carriers, and ILS/alternative capital sources can compress both premiums and underwriting margins.
  • Investment returns and interest rates shape the surplus available for underwriting. Weakness in either—whether from market moves or poor performance—tightens capacity directly.
  • Regulatory, rating, and counterparty risks—including downgrades, elevated capital or collateral requirements, and potential counterparty failures—could meaningfully increase funding costs or constrain capacity.

Competitive landscape

RenaissanceRe competes in a reinsurance market shaped by established multiline giants, specialized Bermudian operators, and a rising tide of alternative capital and ILS managers. The resulting dynamic—more capacity chasing the same risks—has compressed pricing and left the company navigating two overlapping vulnerabilities: the inherent volatility of property-catastrophe and specialty underwriting, and the quieter sensitivities embedded in investment returns and reserve adequacy [Umbrex; CB Insights; MarketBeat].

Private competitors

  • Nephila Capital
  • Fermat Capital Management
  • Twelve Capital
  • Vantage Risk
  • Hamilton Insurance Group

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Catalysts

From recommendation (January 4, 2026)

  • Consensus estimate for EPS in the current year at USD 34.95 - increase of 27.4% in the last 60 days
  • Next earnings call with expected 5.15 USD EPS and 2.4 bn. USD Turnover
  • Morgan Stanley recently raised its price target to USD 290
  • Continuation of inflation-driven premium increases in the catastrophe reinsurance market

Analysis

From recommendation (January 4, 2026)

RenaissanceRe impresses with a combination of operational excellence and structural market advantages. The return on equity of 19.3% and the combined ratio of 77.9% for 2023 show that management understands how to operate profitably in a risky environment. The nature of the business is particularly interesting: primary insurers are required by law to reinsure certain risks, which ensures RenaissanceRe a recession-resistant demand. The long-standing customer relationships and the deep integration of complex risk models create high switching costs. Paradoxically, inflation also acts as a catalyst, as rising claims sums justify higher premiums. The strategic Validus acquisition has sensibly expanded the scope of business without diluting the underwriting discipline. The active share buyback program underlines the management's confidence in its own valuation.

Performance Figures of Renaissancere Holdings Ltd

in USD

1M High / Low
329.57 / 295.38
52W High / Low
329.57 / 231.17
5Y High / Low
329.57 / 124.18
1M
+2.37%
3M
-2.24%
6M
+14.32%
1Y
+29.40%
3Y
+59.09%
5Y
+109.95%

Relative Performance vs Benchmarks

PeriodRenaissancere Holdings Ltd vs DAX vs S&P 500 (SPY)
1M +2.37% +2.35% +1.51%
3M -2.24% -3.10% -8.80%
6M +14.32% +15.83% +4.61%
1Y +29.40% +25.63% +7.14%
3Y +59.09% +4.03% -14.70%
5Y +109.95% +49.62% +22.71%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current4.71.11.13.1
1Y ago5.70.91.02.9
3Y ago21.41.21.24.5
5Y ago16.91.41.05.0

Frequently Asked Questions

From recommendation (January 4, 2026)

Is Renaissancere Holdings Ltd a good investment?

Renaissancere Holdings Ltd has a Leeway Score of 65.1/100, which is rated as Excellent. The Leeway Score combines business quality, fundamental evaluation, and valuation cycle into a comprehensive assessment. A higher score indicates stronger investment quality based on AI-powered fundamental analysis.

What does Renaissancere Holdings Ltd do?

Renaissancere Holdings Ltd is a company characterized by the following investment thesis: RenaissanceRe Holdings Ltd., together with its subsidiaries, provides reinsurance and insurance products in the United States and internationally. The company operates through Property, and Casualty and Specialty segments. The Property segment writes property catastrophe excess of loss reinsurance contracts to insure insurance and reinsurance companies against natural and man-made catastrophes, including hurricanes, earthquakes, typhoons, and tsunamis, as well as winter storms, freezes, floods, fires, windstorms, tornadoes, explosions, and acts of terrorism; and other property class of products, such as proportional reinsurance, property per risk, property reinsurance, binding facilities, and regional U.S. multi-line reinsurance. The Casualty and Specialty segment writes various classes of products, such as directors and officers, medical malpractice, transactional liability, and professional indemnity; automobile and employer's liability, casualty clash, umbrella or excess casualty, workers' compensation, and general liability; financial and mortgage guaranty, political risk, surety, and trade credit; and accident and health, agriculture, aviation, construction, cyber, energy, marine, satellite, and terrorism. The company distributes products and services primarily through intermediaries. It invests in and manages funds. RenaissanceRe Holdings Ltd. was incorporated in 1993 and is headquartered in Pembroke, Bermuda. Renaissancere Holdings Ltd operates in the Financial Services / Insurance - Reinsurance industry is based in USA employs around 1,040 people. Renaissancere Holdings Ltd recently reported revenue of about 11.59B USD, a profit margin of 24.21%, return on equity of 23.37%, a market capitalisation around 13.64B USD, valuation multiples of roughly 5.4x earnings, 1.2x sales, 1.3x book value. Analyst consensus currently expects earnings per share of around 39.28 USD with year‑over‑year growth of 24.35%. Renaissancere Holdings Ltd has an ongoing dividend policy and pays around 1.61 USD per share (0.50% yield).

What are the key metrics for RNR.NYSE?

Key metrics for RNR.NYSE include valuation (P/E 7.4, P/S 1.1, P/B 1.1), profitability (profit margin 14.18%, ROE 13.22%), and growth (revenue -19.20%, earnings -14.20%). Market capitalization is 12.87B USD. These metrics give an overview of the company's financial performance and valuation.

How has Renaissancere Holdings Ltd's stock price performed?

Renaissancere Holdings Ltd's stock has returned — over 1 year, — over 3 years, and — over 5 years. Performance can vary depending on market conditions and company developments.

How is RNR.NYSE valued?

RNR.NYSE has the following valuation metrics: P/E Ratio: 7.4, P/S Ratio: 1.1, P/B Ratio: 1.1. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the growth catalysts for Renaissancere Holdings Ltd?

The key growth catalysts for Renaissancere Holdings Ltd are:
  • Consensus estimate for EPS in the current year at USD 34.95 - increase of 27.4% in the last 60 days
  • Next earnings call with expected 5.15 USD EPS and 2.4 bn. USD Turnover
  • Morgan Stanley recently raised its price target to USD 290
  • Continuation of inflation-driven premium increases in the catastrophe reinsurance market
These factors can positively influence the company's future growth and performance.

What are the key risks when investing in RNR.NYSE?

Key risks for RNR.NYSE include: RenaissanceRe is a Bermuda-based global reinsurer with a focused mandate in property-catastrophe and specialty reinsurance. It competes against a diverse set: global reinsurers like Munich Re, Swiss Re, and Hannover Re; Bermuda-based specialists including Everest, Axis, and Arch; and hybrid players like Markel and Berkshire Hathaway that operate meaningful reinsurance franchises alongside insurance. The business carries three material risk dimensions. Catastrophe-loss volatility remains the structural anchor—large single events can swing results meaningfully. The reinsurance cycle itself creates pricing pressure, particularly as alternative capital and ILS competitors continue to absorb share in soft markets. Investment returns matter more than most realize; capital levels and credit ratings feed directly into underwriting capacity and client appetite, creating a feedback loop that compounds during stressed periods.
  • Material earnings and capital volatility stemming from major natural catastrophe losses, given RenaissanceRe's concentrated exposure to property-cat reinsurance.
  • Adverse reinsurance pricing cycles and intense competition from large reinsurers, specialty carriers, and ILS/alternative capital sources can compress both premiums and underwriting margins.
  • Investment returns and interest rates shape the surplus available for underwriting. Weakness in either—whether from market moves or poor performance—tightens capacity directly.
  • Regulatory, rating, and counterparty risks—including downgrades, elevated capital or collateral requirements, and potential counterparty failures—could meaningfully increase funding costs or constrain capacity.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Renaissancere Holdings Ltd?

Renaissancere Holdings Ltd competes with several listed peers in its sector. RenaissanceRe competes in a reinsurance market shaped by established multiline giants, specialized Bermudian operators, and a rising tide of alternative capital and ILS managers. The resulting dynamic—more capacity chasing the same risks—has compressed pricing and left the company navigating two overlapping vulnerabilities: the inherent volatility of property-catastrophe and specialty underwriting, and the quieter sensitivities embedded in investment returns and reserve adequacy [Umbrex; CB Insights; MarketBeat].
  • Swiss Re (SREN.SIX)
  • Arch Capital Group (ACGL.NASDAQ)
  • AXIS Capital (AXS.NYSE)
  • Everest Group (formerly Everest Re) (EG.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

When does Renaissancere Holdings Ltd report earnings?

Renaissancere Holdings Ltd's next earnings report date is July 22, 2026.

Key Metrics

From recommendation (January 4, 2026)

Market Capitalization
12.87B USD
P/E Ratio
7.43
Analyst Target Price
290.93 USD

Valuation Metrics

P/S Ratio
1.06
P/B Ratio
1.12

Profitability Metrics

Profit Margin
14.18%
Operating Margin
47.24%
Return on Equity
13.22%
Return on Assets
3.25%

Growth Metrics

Revenue Growth
-19.20%
Earnings Growth
-14.20%

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20260.41 USD0.14%0.17%
20260.41 USD0.14%
20250.40 USD0.15%
20250.40 USD0.16%
20250.40 USD0.16%
20250.40 USD0.17%
20240.39 USD0.15%
20240.39 USD0.15%
20240.39 USD0.18%
20240.39 USD0.16%
20230.38 USD0.19%
20230.38 USD0.19%
20230.38 USD0.20%
20230.38 USD0.20%
20220.37 USD0.20%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

66.1%
Beat estimate
32.2%
Miss estimate
+28.06%
Avg surprise when beat
-28.22%
Avg surprise when miss

Reports analyzed: 121

Upcoming earnings report

July 22, 2026
Next earnings date · USD

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus39.28
Range37.89 – 40.16
3 analysts
Est. growth vs prior: 24.35%
Revisions: 7d ↑0 ↓0 · 30d ↑1 ↓1
Next quarter
September 30, 2026
Consensus5.85
Range4.85 – 7.51
3 analysts
Est. growth vs prior: -69.84%
Revisions: 7d ↑0 ↓0 · 30d ↑1 ↓0

Key financial figures

All figures in USD

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue12.75B11.65B9.09B5.05B5.27B
Operating income (EBIT)4.13B3.09B3.20B-1.17B-66.57M
Net income2.68B1.87B2.56B-1.06B-40.16M
Free cash flow3.69B4.16B1.91B1.12B1.23B
Total assets53.80B50.71B49.01B36.55B33.96B
Equity11.61B10.57B9.45B9.86B10.18B
Net debt598.02M210.09M81.14M-23.90M-690.67M
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon